cell-based meat
-
DATABASE (860)
-
ARTICLES (609)
Lenovo Accelerator was co-founded by Lenovo Capital and Incubator Group and Hong Kong-based business park Cyberport in Hong Kong in May 2016. It invests mainly in early-stage startups specialized in cutting-edge technologies and TMT. It is Lenovo Group's first startup accelerator in China. Each startup selected by Lenovo Accelerator receives RMB 500,000 to RMB 1m in funding from Lenovo Group.
Lenovo Accelerator was co-founded by Lenovo Capital and Incubator Group and Hong Kong-based business park Cyberport in Hong Kong in May 2016. It invests mainly in early-stage startups specialized in cutting-edge technologies and TMT. It is Lenovo Group's first startup accelerator in China. Each startup selected by Lenovo Accelerator receives RMB 500,000 to RMB 1m in funding from Lenovo Group.
CNBB Venture Partners is a Dutch fund with 30+ years' experience in the SaaS cloud industry – the company’s main investment focus. Through the VC fund, CNBB invests in funding rounds from €500,000 to €5m, usually provided to companies with a minimum of €1m annual recurring revenue.Through the private equity vehicle, CNBB identifies and acquires Europe-based SaaS companies active in markets with consistent growth, profitability and consolidation. CNBB provides equity investment from €3m to €10m.
CNBB Venture Partners is a Dutch fund with 30+ years' experience in the SaaS cloud industry – the company’s main investment focus. Through the VC fund, CNBB invests in funding rounds from €500,000 to €5m, usually provided to companies with a minimum of €1m annual recurring revenue.Through the private equity vehicle, CNBB identifies and acquires Europe-based SaaS companies active in markets with consistent growth, profitability and consolidation. CNBB provides equity investment from €3m to €10m.
José Neves is best known as the CEO and co-founder of fashion unicorn Farfetch, one of Portugal's most successful startups to date. London-based Neves is also a non-executive director at the British Fashion Council. He has set up his own foundation to spend two-thirds of Farfetch's profits on innovation projects. As an angel investor, he has so far invested in two startups: Portuguese fintech StudentFinance and fashion platform asap54.com where he is also an advisor.
José Neves is best known as the CEO and co-founder of fashion unicorn Farfetch, one of Portugal's most successful startups to date. London-based Neves is also a non-executive director at the British Fashion Council. He has set up his own foundation to spend two-thirds of Farfetch's profits on innovation projects. As an angel investor, he has so far invested in two startups: Portuguese fintech StudentFinance and fashion platform asap54.com where he is also an advisor.
Picart Petcare is the family business of Albert Icart Martori, co-founder of Kibus Petcare. It has been in operation since 1953 and is based in Barcelona. Not usually an investor in tech or startups, it has invested solely in healthy pet food preparation hardware startup Kibus with a pre-seed investment of €120,000 in 1Q 2019. Picart distributes pet food and animal feed in more than 25 European and Middle Eastern markets and is set to be a key distributor of Kibus' hardware.
Picart Petcare is the family business of Albert Icart Martori, co-founder of Kibus Petcare. It has been in operation since 1953 and is based in Barcelona. Not usually an investor in tech or startups, it has invested solely in healthy pet food preparation hardware startup Kibus with a pre-seed investment of €120,000 in 1Q 2019. Picart distributes pet food and animal feed in more than 25 European and Middle Eastern markets and is set to be a key distributor of Kibus' hardware.
Easo Ventures is a Spanish early-stage VC established in 2018 in the Basque city of San Sebastian, offering selected companies either €50,000 or €100,000 according to their development stage. It currently has 29 companies in its portfolio across verticals and technologies, but all must be based in Spain. Its most recent investments include the €2m seed round of medtech IOMED Medical Solutions, which converts medical text into extractable data, and the €1.2m post-seed round of drone company Alerion.
Easo Ventures is a Spanish early-stage VC established in 2018 in the Basque city of San Sebastian, offering selected companies either €50,000 or €100,000 according to their development stage. It currently has 29 companies in its portfolio across verticals and technologies, but all must be based in Spain. Its most recent investments include the €2m seed round of medtech IOMED Medical Solutions, which converts medical text into extractable data, and the €1.2m post-seed round of drone company Alerion.
A Linz-based pre-seed investor founded in 2015, the company currently has 17 companies in its portfolio. Its interests span market verticals and technologies, with tech and non-tech startups supported, and varied geographical locations across Europe. It also runs an online learning lab for startups called Zero21. Its most recent investments include the €2m seed round of Austrian second-hand electronics marketplace refurbed and the €300,000 pre-seed round of German interview platform-as-a-service LAMA.
A Linz-based pre-seed investor founded in 2015, the company currently has 17 companies in its portfolio. Its interests span market verticals and technologies, with tech and non-tech startups supported, and varied geographical locations across Europe. It also runs an online learning lab for startups called Zero21. Its most recent investments include the €2m seed round of Austrian second-hand electronics marketplace refurbed and the €300,000 pre-seed round of German interview platform-as-a-service LAMA.
Having backed some of the most successful US tech companies such as Facebook, PayPal and SpaceX, Oakhouse Partners is a micro-VC headquartered in San Francisco. Led by Jason Portnoy, Andrew Maguire and Stephanie Fernandez, the firm mainly backs companies based in the Bay Area and within the US. Currently focused on breakthrough technologies like blockchain, robotics, 3D printing and CRISPR, Oakhouse Partners typically participates in seed rounds with investments of $250,000–500,000 and in Series A rounds of $1m–1.5m.
Having backed some of the most successful US tech companies such as Facebook, PayPal and SpaceX, Oakhouse Partners is a micro-VC headquartered in San Francisco. Led by Jason Portnoy, Andrew Maguire and Stephanie Fernandez, the firm mainly backs companies based in the Bay Area and within the US. Currently focused on breakthrough technologies like blockchain, robotics, 3D printing and CRISPR, Oakhouse Partners typically participates in seed rounds with investments of $250,000–500,000 and in Series A rounds of $1m–1.5m.
Founded in Boston in 2015, Material Impact is a science-based investment fund backing products that make an impact on real-world problems. It currently has 10 companies in its portfolio, from seed to Series C investments. Its most recent investments have been in the $50m 2020 Series C round of SOURCE Global (formerly Zero Mass Water), the premier off-grid drinking water production tech using solar-powered panels, and in the 2020 $12m Series A round of US electronics protective substance producer actnano.
Founded in Boston in 2015, Material Impact is a science-based investment fund backing products that make an impact on real-world problems. It currently has 10 companies in its portfolio, from seed to Series C investments. Its most recent investments have been in the $50m 2020 Series C round of SOURCE Global (formerly Zero Mass Water), the premier off-grid drinking water production tech using solar-powered panels, and in the 2020 $12m Series A round of US electronics protective substance producer actnano.
Enagás Emprende, part of the Spanish Transmission System Operator (TS) Enagás, is an investment venture backing and accelerating technology-based startups in their scale-up phase. Its portfolio investment mainly includes companies providing renewable gases, green hydrogen, and biomethane, but also sustainable mobility and energy efficiency. With 50 years of experience in energy infrastructures across Spain, the US, Mexico, Chile, Peru, Albania, Greece and Italy, Enagás provides its portfolio startups with mentoring and expertise acting as investors, clients and industry partners.
Enagás Emprende, part of the Spanish Transmission System Operator (TS) Enagás, is an investment venture backing and accelerating technology-based startups in their scale-up phase. Its portfolio investment mainly includes companies providing renewable gases, green hydrogen, and biomethane, but also sustainable mobility and energy efficiency. With 50 years of experience in energy infrastructures across Spain, the US, Mexico, Chile, Peru, Albania, Greece and Italy, Enagás provides its portfolio startups with mentoring and expertise acting as investors, clients and industry partners.
Hong Kong-based Unicorn Capital Partners was founded in 2015 by Tommy Yip, former partner of Emerald Hill Capital Partners.Unicorn is a leading FoF platform that focuses on venture capital fund and direct investment opportunities in China and Asia. It mainly invests in technology, media, telecommunications and healthcare. By December 2019, Unicorn had $800m in assets under management. It also raised over $350m for its fourth fund.
Hong Kong-based Unicorn Capital Partners was founded in 2015 by Tommy Yip, former partner of Emerald Hill Capital Partners.Unicorn is a leading FoF platform that focuses on venture capital fund and direct investment opportunities in China and Asia. It mainly invests in technology, media, telecommunications and healthcare. By December 2019, Unicorn had $800m in assets under management. It also raised over $350m for its fourth fund.
UBS is a Switzerland-based financial institution providing banking, wealth management, and securities services. Originally established in 1862 as the Bank in Winterthur, it is the largest Swiss banking institution. UBS engages in venture capital activities as part of its investment banking services. In 2020, UBS began a partnership with venture capital firm Anthemis to launch UBS Next, a $200m fund that will invest in fintech and other tech startups.
UBS is a Switzerland-based financial institution providing banking, wealth management, and securities services. Originally established in 1862 as the Bank in Winterthur, it is the largest Swiss banking institution. UBS engages in venture capital activities as part of its investment banking services. In 2020, UBS began a partnership with venture capital firm Anthemis to launch UBS Next, a $200m fund that will invest in fintech and other tech startups.
Based in New York City, Lerer Hippeau mainly invests in seed and early-stage startups based in the US. Founded in 2010 by managing partners Kenneth Lerer, Ben Lerer and Eric Hippeau, the VC operates several funds offering initial investments of $1m per startup. Kenneth Lerer is the co-founder of Huffington Post and longtime chairman of BuzzFeed. Hippeau was the CEO of Huffington Post and ex-managing partner of Softbank Capital that invested in Huffington Post.Its 400+ startups also get support for business growth by tapping into tech ecosystems like New York, San Francisco and Los Angeles. Its 80+ exits include Giphy (GIF) that was acquired by Facebook and home-fitness studio Mirror acquired by Lululemon. However, the IPO by portfolio company Bed-in-a-box online retailer Casper was below market expectations. The loss-making e-commerce unicorn went public at $12 a share in February 2020, closing at $13.50 on its first day out, for a market capitalization of less than half the $1.1 billion Casper was valued at in a private funding round in 2019.
Based in New York City, Lerer Hippeau mainly invests in seed and early-stage startups based in the US. Founded in 2010 by managing partners Kenneth Lerer, Ben Lerer and Eric Hippeau, the VC operates several funds offering initial investments of $1m per startup. Kenneth Lerer is the co-founder of Huffington Post and longtime chairman of BuzzFeed. Hippeau was the CEO of Huffington Post and ex-managing partner of Softbank Capital that invested in Huffington Post.Its 400+ startups also get support for business growth by tapping into tech ecosystems like New York, San Francisco and Los Angeles. Its 80+ exits include Giphy (GIF) that was acquired by Facebook and home-fitness studio Mirror acquired by Lululemon. However, the IPO by portfolio company Bed-in-a-box online retailer Casper was below market expectations. The loss-making e-commerce unicorn went public at $12 a share in February 2020, closing at $13.50 on its first day out, for a market capitalization of less than half the $1.1 billion Casper was valued at in a private funding round in 2019.
Founded and headed by Susan Choe in 2018, Katalyst Ventures is based in San Francisco with a debut fund of $34m raised in 2018. Choe is also a partner at another Zipline investor Visionnaire Ventures (VV) also based in Silicon Valley. Katalyst invests in seed and early-stage tech startups with human-centric solutions. About 45% of the VC funds are invested in startups with women as CEO or CTO. By February 2020, the Kalatyst portfolio included 22 enterprises and three exits.The founder of Outspark was removed as CEO by the board of directors due to disagreements over the sale of Outspark. She had used her own money in 2006 to create Outspark, a data-driven publishing platform for game developers. Outspark was eventually sold to Axel Springer and Choe went left the company to join Taizo Son’s venture capital group. In 2013, VV was set up to support tech startups in the US. Choe had worked for Yahoo! and also was the COO of the public-listed holding company of South Korean search and media company NHN.
Founded and headed by Susan Choe in 2018, Katalyst Ventures is based in San Francisco with a debut fund of $34m raised in 2018. Choe is also a partner at another Zipline investor Visionnaire Ventures (VV) also based in Silicon Valley. Katalyst invests in seed and early-stage tech startups with human-centric solutions. About 45% of the VC funds are invested in startups with women as CEO or CTO. By February 2020, the Kalatyst portfolio included 22 enterprises and three exits.The founder of Outspark was removed as CEO by the board of directors due to disagreements over the sale of Outspark. She had used her own money in 2006 to create Outspark, a data-driven publishing platform for game developers. Outspark was eventually sold to Axel Springer and Choe went left the company to join Taizo Son’s venture capital group. In 2013, VV was set up to support tech startups in the US. Choe had worked for Yahoo! and also was the COO of the public-listed holding company of South Korean search and media company NHN.
COO and co-founder of iLoF
Mehak Mumtaz grew up in Pakistan and decided to study biochemistry when she saw her brother suffering from an unknown learning disability. Her parents, both medical doctors, could not get an accurate diagnosis for their son. In her search to understand the molecular mechanisms behind diseases, she applied to study at the University of Oxford. In 2008, she was granted the Reach Oxford Scholarship and graduated with a master’s in biochemistry in 2012. In 2015, the St Hilda’s alumna worked as an undergraduate tutor at Oxford while completing a PhD in pathology, specializing in oncology and cancer biology.In 2018, she worked on a rare cancer project as EIT Health Business Innovation fellow for a year. She left academia and joined a three-month bioentrepreneur bootcamp in Munich and a one-month Lev8 Woman Program at her alma mater’s Oxford Foundry. She joined EY-Parthenon in London as a strategy consultant in April 2019.In 2019, Mumtaz also met the iLoF co-founding team at the EIT Health Wild Card venture-building program. iLoF is a medtech startup that focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.She joined iLoF as COO and co-founder in December 2019 and left her full-time consultancy role at EY in March 2020.
Mehak Mumtaz grew up in Pakistan and decided to study biochemistry when she saw her brother suffering from an unknown learning disability. Her parents, both medical doctors, could not get an accurate diagnosis for their son. In her search to understand the molecular mechanisms behind diseases, she applied to study at the University of Oxford. In 2008, she was granted the Reach Oxford Scholarship and graduated with a master’s in biochemistry in 2012. In 2015, the St Hilda’s alumna worked as an undergraduate tutor at Oxford while completing a PhD in pathology, specializing in oncology and cancer biology.In 2018, she worked on a rare cancer project as EIT Health Business Innovation fellow for a year. She left academia and joined a three-month bioentrepreneur bootcamp in Munich and a one-month Lev8 Woman Program at her alma mater’s Oxford Foundry. She joined EY-Parthenon in London as a strategy consultant in April 2019.In 2019, Mumtaz also met the iLoF co-founding team at the EIT Health Wild Card venture-building program. iLoF is a medtech startup that focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.She joined iLoF as COO and co-founder in December 2019 and left her full-time consultancy role at EY in March 2020.
Chairman of the Board, co-founder, co-inventor of NovoNutrients
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Meatable: Cell-based meat startup secures $47m Series A for scalable technology
The Dutch startup offers a pioneering technology for quickly scaling cell-based meat production while eliminating the need for animal-derived growth media
Meatable joins Royal DSM to create growth media specific for cell-based meat tech
The R&D between the biotech startup and fellow Dutch nutrition conglomerate could help scale and drive the commercial viability of lab-grown meat
Cocuus: Industrial-scale solutions to design and print food
This Spanish startup is pioneering industrial-scale 3D food printing using inkjet and laser technology that prints up to 30 times faster with eye-catching food designs
Big Idea Ventures Founder Andrew D Ive: Asia will lead cell-based meat innovation
In a wide-ranging interview, the managing general partner of the US- and Singapore-based foodtech investor also expounds on his goal to extend sustainability to the rest of the food sector, combining good returns with doing good
New Food Invest: Growing an alternative protein business in Asia
With more than 4bn people, Asia presents unique opportunities and challenges to alternative protein startups. Four leading entrepreneurs shared their experiences at the recent New Food Invest conference
Because Animals: Pioneering cultured meat for pets
The biotech startup is disrupting the pet food processing industry with cell-based food to minimize environmental “pawprints” and promote animal welfare
Future Food Asia 2021: Long road ahead for the clean meat industry
Crucial basic research is still needed to ensure the safety, quality, and production efficiency of lab-grown meat. Concerted public and private sector efforts will accelerate progress
Singapore, the place to start and grow a cellular agriculture startup
A country that imports over 90% of its food supply, Singapore has turned to foodtech, including cellular agriculture, to safeguard food security, supported by proactive regulators
Cubiq Foods: Bioreactor farms producing the food of tomorrow
Growing appetite for meat alternatives expected to fuel demand for Cubiq’s low calorie, Omega 3-enriched lab-grown fats
Good Startup: Alt-protein products can be better than real meat
The investor of Eat Just, Ripple Foods and more expects its portfolio companies will exit in the next four to six years, mostly through acquisition
SWITCH Singapore: Alternative protein sure to take off in Asia, with Singapore as innovation hotbed
In an in-depth discussion, food industry experts say products made with alternative protein in hybrid forms could offer the fastest route to commercialization
Dao Foods unfazed by China tech crackdown, says alternative proteins aligned with state goals
Impact investor Dao Foods expects government support for alternative proteins to come, as it announces second batch of startups, diversifying into fermentation and cell-based proteins
Grain Meat: Focusing on whole cut plant-based meat
With its proprietary fiber weaving technique and specially-designed machinery, Wuxi-based Grain Meat aims to replicate the texture and even the grain of real meat
Biomilq: Creating cell-based mothers’ milk in a lab
With the aim of helping women struggling to breastfeed, Bill Gates-backed Biomilq is disrupting the $45bn baby formula industry developing lab-grown breast milk from mammary epithelial cells
Qorium: Lab-grown premium leather for the future of luxury
The Dutch biotech startup co-founded by cell-based meat pioneer Mark Post is targeting the luxury goods market with its “clean leather” sheets made from cultivating bovine skin cells, and plans to raise up to €100m
Sorry, we couldn’t find any matches for “cell-based meat”.
POPULAR DATABASE
